Nectar Lifesciences informs about quarterly statement on investor complaints

06 Apr 2016 Evaluate

Nectar Lifesciences has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

18.30 -0.28 (-1.51%)
31-Dec-2025 09:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.20
Dr. Reddys Lab 1262.00
Cipla 1491.25
Zydus Lifesciences 908.20
Lupin 2087.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×